Fig 3.tif (2.02 MB)
Survival curves by endocrine therapy (tamoxifen vs. tamoxifen + OS/OA).
dataset
posted on 2016-02-11, 13:12 authored by Cong Xue, Roujun Peng, Ye Cao, Shusen Wang, Yanxia Shi, Xin An, Fei Xu, Zhongyu Yuan(A) and (B), DFS and OS of patients < 40 y/o + normal menses; (C) and (D), DFS and OS of patients < 40 y/o + amenorrhoea; (E) and (F), DFS and OS of patients ≥ 40 y/o + normal menses; G and H, DFS and OS of patients ≥ 40 y/o + amenorrhoea.
